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The ability of Neisseria species to use iron compounds and to compete with
iron-binding proteins was examined with deferrated defined medium and the iron
chelator deferoxamine. All Neisseria species were able to assimilate a variety of
ferric and ferrous iron salts. They were not able to efficiently solubilize an
inorganic iron salt such as ferric nitrate, but were able to use iron chelated by
citrate, oxalacetate, pyrophosphate, or nitrilotriacetate. Each of the 95 Neisseria
isolates examined was able to use hemin as a sole source of iron, and most, but
not all, of the isolates were able to obtain iron from hemoglobin. Heated human
serum stimulated growth of all gonococci, meningococci, and some commensal
Neisseria species in iron-deficient medium. All gonococci and meningococci were
able to scavenge iron from 25% saturated transferrin, whereas most commensal
organisms were inhibited by this iron-binding protein. The ability to compete
with transferrin was specific, since partially saturated conalbumin was bacterio-
static for all Neisseria species. Although the pathogenic Neisseria species were
able to compete more efficiently with transferrin for iron than were the nonpath-
ogenic Neisseria species, no correlation was observed between the virulence of
different strains or colony types of gonococci and the ability to scavenge iron in
vitro from transferrin or other chelators.
One mechanism by which an animal host dis-
courages colonization or invasion by microorga-
nisms may be limitation of the availability of an
essential nutrient such as iron. In tissues, the
concentration of free iron is far below that re-
quired for microbial growth. Iron present in the
host is sequestered in hemin compounds, as fer-
ritin, or bound to the proteins lactoferrin or
transferrin, which function in iron chelation,
transport, and exchange (24). The presence of
transferrin in serum and of lactoferrin in secre-
tions accounts, in part, for the microbiostatic
activity of these host fluids for some bacteria
and fungi (4, 5, 24).
The efficiency with which some microorga-
nisms obtain iron in the host may be a deter-
minant of pathogenicity (4, 15,24,27). In chicken
embryos, Payne and Finkelstein (19, 20) and
Payne et al. (21) observed that administration
of iron dextran enhanced the infectivity of rela-
tively avirulent colonial type 4 gonococci but did
not alter the 50% lethal dose for type 1 orga-
nisms. Treatment with conalbumin, the iron-
binding protein in chicken egg white, decreased
the virulence of most type 1 gonococci isolated
from localized genital infections but did not af-
fect the 50% lethal dose of gonococci capable of
causing disseminated gonococcal disease. These
investigators proposed that the ability of certain
strains or colony types of gonococci to scavenge
iron in the host correlated with, and might be
responsible for, the virulence of the organisms.
The mechanisms by which gonococci obtain
iron in the host have not been characterized.
The purpose of this investigation was to describe
some of the systems by which gonococci obtain
iron. For comparative purposes we also exam-
ined the ability of Neisseria meningitidis and
the commensal Neisseria species to compete
with the iron-binding proteins transferrin and
conalbumin and to use iron compounds which
might serve as iron sources in vivo.
MATERIALS AND METHODS
Organisms. Strains of N. gonorrhoeae were pri-
marily clinical isolates obtained from either Durham
County Health Department, Durham, N.C., Duke
University Hospital, Durham, N.C., or North Carolina
Memorial Hospital, Chapel Hill, N.C. Ofthe 29 isolates
examined for ability to use various iron sources, 7 were
isolated from joint or blood cultures of persons having
disseminated gonococcal infection (DGI). Laboratory
strains of N. gonorrhoeae included F62 (obtained from
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D. S. Kellogg, Jr., Centers for Disease Control, At-
lanta, Ga.) and FA19 (obtained from A. Reyn, Statens
Seruminstitut, Copenhagen, Denmark). FA19 has
caused disseminated disease in a laboratory-acquired
infection. Of the 29 gonococcal isolates, 13 were resist-
ant to the bactericidal activity of serum (8). Twenty
strains were amino acid prototrophs, and the remain-
ing isolates represented a variety of auxotypes (6).
Four of these gonococcal isolates, FA534, FA852,
FA853, and FA854, lacked plasmids detectable by
agarose gel electrophoresis (16). Additional gonococcal
strains obtained from the Centers for Disease Control;
J. S. Knapp, Neisseria Reference Laboratories, Seat-
tle, Wash.; Durham County Health Department; and
North Carolina Memorial Hospital were used for de-
terminations of the minimal inhibitory concentrations
(MICs) of chelators for isolates from disseminated and
urogenital infections. Colonial type 4 organisms were
used in all assays, unless otherwise noted, and were
selected by the method of Kellogg et al. (13) on Difco
GC base agar (GCBA) containing 1% Kellogg defined
supplement I and 0.1% supplement II.
Meningococci representing groups A, B, C, X, Y,
and Z were obtained from North Carolina Memorial
Hospital; North Carolina State Health Department,
Raleigh, N.C.; Walter Reed Army Medical Center,
Washington, D.C.; and M. H. Mulks, Tufts-New Eng-
land Medical Center, Boston, Mass. Commensal Neis-
seria species included American Type Culture Collec-
tion strains and isolates obtained from J. S. Knapp,
Neisseria Reference Laboratories; M. H. Mulks, Tufts-
New England Medical Center; North Carolina State
Health Department; and North Carolina Memorial
Hospital.
Media. The deferrated defined liquid medium
(DDL) used in most of these studies was a modifi-
cation of Catlin's NEDF (6). The original NEDF for-
mula was altered by the omission of ethylenediamine-
tetraacetic acid, glycerin, polyvinyl alcohol, Tween 80,
glucose, hemin, nitrilotriethanol, and ferric nitrate and
by the inclusion of 45 mM sodium lactate, 20 mM
HEPES (N-2-hydroxyethylpiperazine-N'-2-ethane-
sulfonic acid), and 500 1iM dibasic and monobasic
potassium phosphate. The medium was prepared at
5x strength, and the pH was adjusted to 7.1. The
medium was deferrated by using the ion-exchange
resin Chelex-100 (Bio-Rad Laboratories). Chelex-100
(sodium form) was soaked for approximately 2 h in
sterile 200 mM NaCl and then rinsed with 10 to 15
volumes of sterile deionized water. The resin was
added to sterile medium and mixed very gently with
a magnetic stirrer overnight at 4°C. The medium was
sterilized by passage through a 0.45-,um filter, which
also removed the Chelex-100, and then was treated
with fresh Chelex-100 two additional times for 8 to 16
h. Approximately 120 g of Chelex-100 was used to
deferrate 1 liter of5x medium. The deferrated medium
was supplemented with 100 ,luM CaCl2 and 1.0 mM
MgCl2, and the pH was adjusted to 7.45. Some lots of
Chelex-100 were found to be more satisfactory than
others in selectively removing iron without removing
other components necessary for the growth of the
organisms. Concentrated Chelex-100-treated DDL
was stored frozen at -20°C. Before use, DDL was
supplemented with 20 mM sodium bicarbonate. The
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concentration of iron in the lx deferrated medium, as
determined by atomic absorption spectrophotometry,
was 0.02 to 0.07,uM.
A defined agar medium (DA) was made from DDL
by the addition of 0.8% Sigma type II agarose. DA had
a sufficiently high concentration of contaminating
iron, approximately 2 ,iM, that organisms were not
iron limited (i.e., addition of iron did not affect the
rate or extent of growth). The potent iron chelator,
deferoxamine mesylate (DF [Desferal, Ciba Pharma-
ceutical Co.]), was used in some assays to bind all free
iron in the medium. Iron complexed with DF could
not be assimilated by any of the Neisseria species.
To assess the effects of potential iron-solubilizing
compounds on the use of inorganic and organic iron
sources, a low-chelate modification of DA (LC-DA)
was used. LC-DA was prepared by substituting 28mM
glucose for sodium lactate, using only 300,iM dibasic
and monobasic potassium phosphate, and omitting
sodium acetate and oxalacetate. LC-DA was not de-
ferrated with Chelex-100.
Except for disposable pipettes (Coming Glass
Works), which were found to contribute negligible
amounts of contaminating iron, all glass and plastic
items used were soaked in 3 N nitric acid and rinsed
with deionized water. Plastic items were sterilized by
autoclaving, and glassware was sterilized in a hot-air
oven.
Iron-binding and iron-containing compounds.
Human transferrin (Sigma Chemical Co.) and chicken
egg white conalbumin (Sigma) were deferrated and
further purified by chromatography, using Sepharose
CL-6B (Pharmacia Fine Chemicals) (2). Preparations
of transferrin to which no further iron was added were
4% iron saturated as determined by atomic absorption
spectrophotometry of samples of known protein con-
centration. The iron-binding capacity of these proteins
dissolved in 10 mM HEPES-150 mM NaCl-10 mM
sodium bicarbonate buffer (pH 7.4) was also deter-
mined by titration with ferric nitrilotriacetate (9).
Deferrated transferrin and conalbumin were made 25%
saturated by addition of 1 mM ferric nitrilotriacetate,
followed by passage through a Sephadex G-25 (Phar-
macia) column equilibrated with the HEPES-NaCl-
bicarbonate buffer to remove any unbound ferric ni-
trilotriacetate (14). Filter-sterilized transferrin and
conalbumin were stored at either 4 or -70°C. Purified
preparations of transferrin and conalbumin were used
in all assays except those used to determine MICs.
Hemin (Sigma) was dissolved in a small quantity of
triethanolamine, diluted to the appropriate concentra-
tion with deionized water, and then sterilized by filtra-
tion. Human hemoglobin (Sigma) was dissolved in
deionized water, dialyzed, and sterilized by filtration.
Human serum from healthy donors was pooled and
stored at -70°C and was heat inactivated by incubat-
ing for 30 min in a 56°C water bath.
Plate assays for use of iron compounds. After
selective passage on GCBA, organisms were passaged
twice on DA. The addition of agarose to DDL resulted
in approximately 2,iM Fe in DA, which was sufficient
for growth. Organisms from an 18-h culture were sus-
pended in DDL and grown for 2 to 4 h in an incubator
shaker at 35°C with an atmosphere of 5 to 10% C02.
The density of the cultures was adjusted to approxi-
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mately 20 Klett units (approximately 108 colony-form-
ing units per ml) with a Klett-Summerson spectropho-
tometer with a 500- to 570-nm filter. The culture was
then diluted 1:100 in DDL, and 0.5 ml of the diluted
culture was added to 15 ml of molten DA which
contained 10 mM sodium bicarbonate and either no
additional supplements or 200 jiM DF. After the me-
dium solidified, wells of approximately 8 mm in di-
ameter were cut in the agar. The wells were charged
with 40-,il samples of either 10 mM Fe(NO3)2, 75 ,iM
hemin, 200 uM hemoglobin, undiluted heated serum,
500 jiM transferrin, or 500 ,uM conalbumin dissolved
in the HEPES-NaCl-bicarbonate buffer. Plates were
incubated at 35°C in an atmosphere of 5 to 10% CO2.
Zones of growth stimulation or growth inhibition were
measured after 22 to 24 h and after 48 h of incubation.
To assess the effects of potential iron-solubilizing
compounds on the use of inorganic or organic iron
sources, the same procedure was followed except that
LC-DA, rather than DA, was used as the growth
medium. Wells were filled with 40-ul samples of 10
mM Fe(NO3)3 or with 100 mM solutions of oxalacetic
acid, nitrilotriacetate, sodium citrate, sodium succi-
nate, sodium maleate, sodium lactate, sodium acetate,
sodium pyrophosphate, or dibasic and monobasic po-
tassium phosphate.
Growth kinetics in liquid deferrated medium.
After at least two passages on DA, organisms were
grown overnight in DDL at 35°C in an atmosphere of
5 to 10% CO2. Cultures were diluted into fresh DDL
and incubated in a CO2 shaker incubator to obtain
logarithmic-phase cells. The cultures were then
washed twice in DDL and inoculated into warmed
DDL to which various iron sources or iron chelators
had been added. The cultures were incubated at 35°C
in a shaker incubator with 5 to 10% C02, and the
turbidity was read with a Klett-Summerson spectro-
photometer.
Growth in serum. After selective passage on
GCBA, organisms were passaged twice on DA, sus-
pended to an optical density of 30 Klett units, and
grown for approximately 2 to 3 h in a shaker incubator
in the presence of 5% CO2. The turbidity of logarith-
mic-phase cultures was then adjusted to an optical
density of 30 Klett units, and serial 10-fold dilutions
were made in DDL. A 15-,lI amount of each diluted
culture was added to sterile microtiter wells containing
150 ,il of fresh or heat-inactivated pooled human serum
or DDL. All wells were supplemented with 10 mM
sodium bicarbonate. After 24 and 48 h, wells were
examined for evidence of visible growth. Only wells
which showed visible growth yielded viable organisms
upon subculture.
MICs of iron-binding compounds. MICs for DF
and conalbumin were determined for 44 strains of N.
gonorrhoeae. After type 1 or 4 colonies had been
selected on GCBA, organisms were subcultured at
least twice on DA. Subculture back to GCBA revealed
that cultures of type 1 gonococci usually still consisted
of >90% type 1 organisms. For agar dilution assays,
organisms were suspended and adjusted to 30 Klett
units in DDL and then diluted 1:50 in DDL. With a
calibrated platinum loop, approximately 0.005 ml of
the diluted culture was inoculated onto plates of DA
either without further additions or with increasing
concentrations of DF, unpurified transferrin, or un-
purified conalbumin. Unpurified transferrin and con-
albumin contained, respectively, 0.001 and 0.015% con-
taminating iron. Concentrations of these iron-binding
compounds tested were as follows: 0.1, 0.2, 0.4, 0.6, 0.8,
and 1.0 ,uM (conalbumin); 0.5, 1.0, 2.0, 4.0, and 8.0 yM
(DF); 0.5, 1.0, 2.0, 5.0, and 20.0 MM (transferrin). Me-
dium containing 8MM DF, 1 or 0.5MuM conalbumiin, or
20 MuM transferrin to which 40 jiM Fe(NO3)3 had been
added was used for growth controls. The lowest con-
centration of chelator which markedly inhibited
growth compared with controls after 48 h was consid-
ered the MIC. Each isolate was tested twice, each time
with a different batch of medium.
To determine broth dilution MICs, colony type 1 or
4 organisms which had been passaged twice on DA
were grown in DDL overnight in a CO2 incubator
without shaking. Cultures inoculated with type 1 gon-
ococci contained greater than 75% type 1 organisms.
Cultures were adjusted to a density of 30 Klett units
and diluted by 10-fold serial dilutions in DDL, and 20
M1 of various dilutions was added to microtiter wells
containing 0.2 ml of DDL either without additional
supplements or with 0.01, 0.025, 0.05, 0.10, 0.25, 1.0,
2.5, or 5.0 MM conalbumin. MICs were determined by
using inoculum sizes of approximately 104, 105, and 106
organisms per ml.
Statistics. The Mann-Whitney two-sample test
was used to analyze differences in distribution of
growth responses to iron compounds or chelators ex-
hibited by DGI and local isolates or type 1 and 4
gonococci.
RESULTS
Use of iron-containing compounds. Gon-
ococci grew well when inoculated onto DA,
which contained about 2MAM iron (Fig. 1, bottom
row). However, when they were inoculated onto
the same medium containing 200 MM DF, no
growth occurred except around wells containing
a useable iron source (Fig. 1, top row). Iron salts
such as ferric nitrate, ferric chloride, ferric cit-
rate, ferric ammonium citrate, ferrous sulfate,
and ferrous ammonium sulfate stimulated the
growth of N. gonorrhoeae FA19 and F62, a
group C N. meningitidis isolate, N. lactamica
ATCC 23970, and N. perflava ATCC 14799.
All Neisseria isolates were able to use hemin
as a sole iron source in the presence of sufficient
DF to bind any available free iron. Of 29 gono-
coccal isolates, 9 of which were serum-sensitive
prototrophs, 11 were unable to obtain the iron
required for growth from hemoglobin. For many
strains of gonococci, growth around wells con-
taining hemoglobin was uneven and was de-
tected only after 48 h of incubation, in contrast
to the positive results obtained at 24 h with
Fe(NO3)3 and hemin. When strain FAl9 was
first grown in the presence of hemoglobin, zones
of growth appeared after 24 h of incubation. The
delayed growth response suggests that an induc-
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FIG. 1. Growth response of (A) N. gonorrhoeae FA19, (B) a group C N. meningitidis isolate, and (C) N.
perflava ATCC 14799 to iron-containing and iron-binding compounds in DA containing 200 pM DF (top row)
and in DA without DF (bottom row). DA contains sufficient iron (ca. 2 pM) to allow matt growth in the
absence of DF, although this is not easily seen in the figure (bottom row). Wells in the top row of plates
contained the following (counterclockwise from top well): Fe(NO3)3, hemin, hemoglobin, heated serum, 4%
saturated transferrin, 25% saturated transferrin, and 25% saturated conalbumin. Wells in the bottom row of
plates contained the following (counterclockwise from top well): heated serum, 4% saturated transferrin, 25%
saturated transferrin, and 25% saturated conalbumin. Zones of inhibition are present around well 7 on plates
A and B and around all wells on plate C.
ible system, or possibly a protease, might be
involved in obtaining iron or hemin from he-
moglobin. Of the 21 meningococcal strains ex-
amined, one group A isolate was unable to use
hemoglobin as an iron source. Growth of all
commensal isolates was stimulated by hemoglo-
bin in medium containing 200 ,uM DF. The rea-
son for the heterogeneous growth response to
hemoglobin exhibited by some isolates is un-
known.
Competition with transferrin and conal-
bumin. The ability of organisms to compete
with the iron-binding proteins transferrin and
conalbumin for iron was evaluated on iron-suf-
ficient medium (DA, ca. 2pM iron) and iron-free
medium (DA plus 200,M DF, which chelated
all free iron). Results obtained with the two
assay systems were complementary. For exam-
ple, organisms which were stimulated by trans-
ferrin in medium totally deferrated by 200 pM
DF exhibited growth around wells containing
transferrin in iron-sufficient medium. If transfer-
rin or conalbumin was inhibitory in medium
lacking DF, no growth stimulation was observed
in medium limited in iron by DF (Fig. 1). Heat-
ing transferrin (56°C, 30 min) did not affect the
results.
When the concentration of DF in plates was
decreased, the diameter of the zones of growth
stimulation around wells containing a fixed con-
centration of free inorganic iron increased sub-
stantially. Zones of growth around wells contain-
ing hemin, hemoglobin, serum, and partially sat-
urated transferrin were unaffected by the con-
centration ofDF (data not shown). Growth stim-
ulation by these iron sources was therefore not
due to contamination by free iron.
Transferrin is normally 25 to 35% saturated in
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serum (1, 24). Growth of all 29 gonococcal iso-
lates was stimulated by 25% saturated transfer-
rin after 48 h of incubation on DA containing
200 yM DF (Table 1). One strain, FA3003, ap-
peared to be somewhat less efficient than other
gonococci in scavenging iron from 25% saturated
transferrin, since zones of growth in the presence
of DF appeared only after 48 h of incubation
rather than at 24 h as observed with most gon-
ococci. All meningococcal isolates were able to
obtain the iron required for growth from 25%
saturated transferrin. Only one group A menin-
gococcus isolate and two strains of the gonococ-
cus, FA3003 and FA1579, were inhibited by 4%
saturated transferrin after 48 h of incubation in
iron-sufficient DA. Four percent saturated trans-
ferrin was inhibitory at 24 h on DA for four
additional strains of the gonococcus, FA852,
FA854, FA1513 (local disease isolates), and
FA1035 (a DGI isolate), but these organisms
overcame the bacteriostatic effects of transferrin
and were able to compete successfully with the
protein for iron after 48 h of incubation.
In contrast to the pathogenic Neisseria
strains, most of the commensal isolates were not
able to obtain iron required for growth on DA
containing 200 ,iM DF from 25% saturated trans-
ferrin and were inhibited by transferrin in iron-
sufficient DA (Fig. 1 and Table 1). Of 45 tested
nonpathogenic strains, most of which were N.
lactamica or N. flavescens isolates, 10 were able
to scavenge iron from 25% saturated transferrin,
but growth response to the transferrin for 5 of
these isolates was slow. Only 5 of the 45 com-
mensal Neisseria species were able to compete
with 4% saturated transferrin for iron in the
medium.
Conalbumin which was 25% saturated in-
hibited the growth of all strains of Neisseria in
iron-sufficient DA and did not stimulate the
growth of any of the isolates in iron-limited
conditions (DA containing 200 /LM DF). The size
of zones of inhibition around conalbumin-con-
taining wells did not change with prolonged in-
cubation.
Kinetics ofgrowth in DDL. Gonococci (Fig.
2) and meningococci (not shown) grew normally
for a few mass doublings in DDL (<0.07 ,uM
iron), but then were iron limited. More rapid
growth inhibition was observed in DDL contain-
ing DF or conalbumin. The initial growth in
DDL was presumnably due to residual iron in
intracellular pools, as well as to small amounts
of iron renmaining in DDL. Kinetics of growth of
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FIG. 2. Growth of N. gonorrhoeae FA19 in DDL
without additional supplements (0) or with 10 .LM
Fe(NO3)3 (0), 2.5 25% saturated transferrin (U),
2.5 p.M 25% saturated transferrin and 10 p.M DF (a),
2.5 pM 25% saturated conalbumin (A), or 10 p.M DF
(A).
TABLE 1. Growth stimulation of Neisseria species by iron sources in medium containing excess DF
No. of colonies whose growth was stimulated by the following
iron sources:
Organism No. of isolates Transferrin Transferrin Conalbumin
(25% satu- (4% satu- (25% satu- Heated serum
rated) rated) rated)
N. gonorrhoeae 29 29 27 0 29
N. meningitidis 21 21 20 0 21
N. lactamica 6 5 2 0 6
N. flavescens 3 3 2 0 3
N. sicca 9 1 1 0 1
N.flavaa 11 1 0 0 9
N. mucosa 3 0 0 0 3
N. sicca or N. flavab 13 0 0 0 3
a Includes N. flava, N. subflava, and N. perflava.
b Patient isolates from Chapel Hill, N.C., identified as N. sicca or N. subflava.
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3e conditions. The bacteriostatic inoculum size as low as 103 organisms per ml.
aturated conalbumin or of DF Plate assays (Fig. 1, bottom row; Table 1)
,d by saturation with excess in- showed that heated serum was not bacteriostatic
he addition of 25% saturated for gonococci and that all gonococci were able to
?letely reversed iron limitation obtain from serum the iron required for growth.
the presence of excess DF. All meningococci and many of the commensal
*wth exhibited by inoculum sizes Neisseria species also were able to obtain iron
,anisms per ml of gonococci in from serum in medium containing DDL. Since
DDL or DDL supplemented some of these commensal isolates could not com-
403)3 were monitored by deter- pete with transferrin for iron, other organic iron
nber of viable colony-forming compounds in serum were presumably serving
Kinetics of growth were the as iron sources. There was sufficient hemin in
Dfwhether organisms previously serum to support the growth of Haemophilus
vn in iron-sufficient [10 yM influenzae in plate assays.
orDDL without additional iron. Iron acquisition by gonococci lacking
3se conditions no inoculum-de- plasmids. Each of four strains of gonococci
observed for gonococci in iron- which lacked detectable plasmids was able to
obtain iron from 25% saturated transferrin and
the results obtained with gono- to utilize Fe(NO3)3, hemin, and iron-containing
ngococci, the addition of 25% compounds in serum for growth. Four percent
ferrin inhibited growth of N. transferrin was somewhat inhibitory for two
19243 in DDL (Fig. 3). Growth strains, FA852 and FA854, after 24 h of incuba-
ansferrin was identical to that tion, but these strains later overcame the bac-
conalbumin or DF (data not teriostatic effects of the protein.
ion by transferrin, conalbumin, Iron scavenging by gonococci having dif-
reversed by adding sufficient ferences in pathogenic potential. Several ap-
ium to saturate the binding ca- proaches were used to detect possible differences
elators. in the ability of various gonococci to compete
)onse to serum. Four serum- with iron chelators in vitro. We reasoned that
of gonococci isolated from local differences in iron-scavenging ability might be
ive serum-resistant DGI strains detected by determination of the least amount
their ability to grow in human of conalbumin or DF which would inhibit growth
rganisms of all isolates were able when incorporated into agar medium. Type 1
h in heated serum even with an organisms of each of 12 DGI strains and 16
urogenital isolates were inhibited by 2.0 ,eM DF
and 0.4 AM conalbumin (Table 2). Type 4 gon-
ococci from seven strains had the same MIC for
DF or conalbumin as did type 1 organisms from
the same isolates (Table 2). All strains grew in
the presence of 20 AM transferrin. Each of seven
additional DGI isolates and six urogenital iso-
lates which were composed of a mixture of col-
ony types 1 and 4 before being tested also had
MICs of 2.0 for DF, 0.4 for conalbumin, and >20
1M for transferrin (data not shown). MICs were
determined for conalbumin and DF after 48 h of
incubation to allow endpoints to be accurately
read for strains of gonococci which grew slowly
on DA. However, the concentration of conalbu-
min or DF which markedly inhibited the growth
of each isolate was the same after 24 or 48 h of
, incubation. Plates containing 0.4 pM conalbu-
2 4 6 8 10 min, which exhibited no growth at 48 h, showed
HOURS a faint haze of growth for all strains upon pro-
ofN. subflavaATCC 19243 in DDL longed incubation. Growth inhibition by conal-
1 supplements (0) or with 10 ,P4 bumin was reversed by the addition of Fe(NO3)3.
LM 25% saturated transferrin (-), Of the total 44 gonococcal isolates tested in
?rrin and 10 piM Fe(NO3)3 (O) or 2.5 these assays, 3 were inhibited by lesser amounts
conalbumin (A). of conalbumin or transferrin than were the other
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TABLE 2. MICs for conalbumin, DF, and
transferrin determined by the agar dilution method




type Iso- DF Conal- Trans-
lates bumin ferrin
1 DGI 12 2.0a 0.4 >20
Urogenitalb 16 2.0 0.4 >20
4c DGI 2 2.0 0.4 >20
Urogenital 5 2.0 0.4 >20
a MICs for DF, conalbumin, and transferrin were identical
for all isolates in each of two experiments.
'Strains included two lacking detectable plasmids.
c Type 4 organisms were isolated from type I colonies of
strains included above.
41 isolates, but they failed to grow on control
plates containing conalbumin or transferrin and
excess iron and were excluded from this study.
Presumably, these organisms were sensitive to
some component contaminating the unpurified
preparations of conalbumin and transferrin used
for the MIC assays.
When type 4 organisms of the 10 local disease
isolates were compared with 4 DGI isolates on
iron-limited medium (DA plus 200 /LM DF), sizes
of zones of growth stimulation around wells con-
taining Fe(NO3)3, hemin, and 25% saturated
transferrin or 4% transferrin (data not shown)
were not significantly different (P > 0.4 for each
assay). The sizes of zones of inhibition on iron-
sufficient DA around wells containing conalbu-
min were also not significantly different (P >
0.4). Similar assays showed no differences be-
tween type 1 and 4 organisms of strains FA19
and F62 (data not shown). In microtiter broth
dilution assays containing an inoculum of <106
colony-forming units per ml, type 1 and 4 cells
of strains FA19 and F62 had identical MICs for
conalbumin (0.1,M).
Use of iron sources in medium deficient
in iron-solubilizing compounds. N. gonor-
rhoeae FA19 and F62, a group A meningococcal
isolate, N. lactamica NRL 30011, N. subflava
NRL 30017, and N. flava NRL 9993 were tested
in assays employing modified DA containing
minimal amounts of potential iron-solubilizing
components (LC-DA). With DA containing 200
,MM DF, zones of growth occurring around wells
containing 10 mM Fe(NO3)3 were approximately
17 to 19 mm in diameter. In contrast, with LC-
DA containing 200 ,uM DF, zones of growth
around wells containing 10 mM Fe(NO3)3 were
<10 mm in diameter. In LC-DA, large elliptical
zones of growth stimulation were obtained
around one side of the Fe(NO3)3 well when an
adjacent well contained sodium citrate, nitrilo-
triacetate, pyrophosphate, or oxalacetate (Fig.
4). The same pattern of growth stimulation was
observed when the concentrations of DF and
Fe(NO3)3 were decreased 20-fold. Sodium lac-
tate, acetate, succinate, maleate, or phosphate
did not increase the availability of iron for or-
ganisms in these assays. Compounds such as
citrate and nitrilotriacetate, which facilitated the
use of Fe(NOa)a, did not stimulate growth of the
organisms in LC-DA with or without DF. Pre-
sumably, in LC-DA, iron in excess of that re-
quired to saturate the DF was not in soluble
form and therefore did not diffuse readily in the
medium. Citrate, nitrilotriacetate, pyrophos-
phate, and oxalacetate appeared to effectively
solubilize excess iron in LC-DA, making it avail-
able for assimilation by organisms seeded into
the medium. The growth stimulation observed
by Fe(NO3)3 in DA containing 200 MM DF (Fig.
1) or in DDL (Fig. 2 and 3) was presumably due
to the presence of sufficient oxalacetate to solu-
bilize Fe(N03)3. In other experiments, the ma-
jority of added 55FeC13 (1 MLM) was insoluble in
low-chelate liquid medium and was trapped on
0.45-,um filters (Gelman GA-6), whereas over
99% was soluble in DDL (data not shown).
On LC-DA, zones of growth stimulation
around Fe(N03)3-containing wells did not in-
crease with prolonged incubation. Neither fil-
trates of gonococcal cultures from iron-limited
DDL nor a loopful of gonococci grown on DA
enhanced the use of Fe(NO3)3 on LC-DA me-
dium. This suggested that in this assay system
gonococci were not secreting sufficient quanti-
ties of iron-solubilizing compounds (sidero-
phores) to facilitate use of available iron.
In contrast to the results obtained with
Fe(NO3)3, sizes of zones of growth stimulation
around hemin, serum, and transferrin in LC-DA
were comparable to those obtained with DA.
Therefore, use of these iron compounds was not
dependent on the presence of iron-solubilizing
agents in the medium.
DISCUSSION
In vitro assays with a deferrated defined me-
dium and the potent iron chelator DF were used
to determine some of the mechanisms by which
gonococci and other Neisseria species acquire
iron. Gonococci, meningococci, and the com-
mensal Neisseria species assimilated a variety
of ferric and ferrous iron salts. These organisms,
however, apparently were unable to efficiently
solubilize an inorganic iron salt such as
Fe(NOa)3. Compounds such as citrate, oxalace-
tate, pyrophosphate and nitrilotriacetate facili-
tated use of Fe(NO3)3, presumably by solubi-
lizing inorganic iron. Gonococci were able to
grow in medium containing as much as 10 mM
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FIG. 4. Ability of iron-solubilizing compounds to facilitate use of inorganic iron by N. gonorrhoeae F62 in
LC-DA containing 200X tM DF. Wells in the plate on the left contained the following (beginning with the well
indicated by an arrow and proceeding counterclockwise): 25% saturated transferrin; Fe(NO3)3; inner well,
Fe(NO3)3, and outer well, sodium citrate; sodium citrate; inner well, hemin, and outer well, sodium citrate;
hemin; inner well, 25% saturated transferrin, and outer well, sodium citrate. Wells in the plate on the right
contained the following: Fe(NO3)3; inner well, Fe(NO3)3, and outer well, nitrilotriacetate; nitrilotriacetate;
inner well, Fe(NO3)3, and outer well, sodium lactate; sodium lactate; inner well, Fe(NO3)3, and outer well,
dibasic and monobasic potassium phosphate; dibasic and monobasic potassium phosphate; inner well,
Fe(NO3)3, and outer well, oxalacetic acid; oxalacetic acid.
sodium citrate or nitrilotriacetate, suggesting
that they either possessed a high-efficiency sys-
tem for competing with these compounds for
iron, were able to mediate release of iron from
the chelators, or were able to directly assimilate
these ferric chelates.
These observations are similar to those of
Archibald and DeVoe (3),*who found that che-
lators such as citrate, pyrophosphate, and lac-
tate facilitate use of relatively insoluble iron
compounds by meningococci. These investiga-
tors were unable to obtain evidence for a men-
ingococcal siderophore. Yancey and Finkelstein
(Abstr. Annu. Meet. Am. Soc. Microbiol. 1980,
B83, p. 31), however, have reported the isolation
of a dihydroxamate from gonococci and menin-
gococci which has the properties of a sidero-
phore. In view of the low efficiency with which
the Neisseria species were able to solubilize iron
in the LC-DA system, the siderophore described
by Yancey and Finkelstein either was not pro-
duced in appreciable quantities by the strains
that we studied in LC-DA, was cell-bound, or
diffused poorly.
All Neisseria species were able to use hemin
as a sole source of iron. Because most, but not
all, gonococcal and meningococcal isolates were
able to scavenge iron from hemoglobin, an ad-
ditional mechanism was probably required for
release of hemin from the globin molecule.
Each of 50 tested isolates of N. gonorrhoeae
and N. meningitidis was able to effectively scav-
enge iron from 25% saturated transferrin even in
the presence of excess DF. Archibald and DeVoe
(2) also have demonstrated that meningococci
are able to obtain iron from transferrin. In con-
trast, only 10 of 45 isolates of various commensal
Neisseria species were able to scavenge iron
from 25% saturated transferrin; the remainder
were growth inhibited by transferrin. Because
the pathogenic Neisseria species, in contrast to
most commensal organisms, possess the capabil-
ity of scavenging iron from transferrin, it is pos-
sible that this is an attribute which contributes
to the survival of these organisms in the host. In
support of such speculation is a recent study by
Holbein (10) in mice which showed a positive
correlation between transferrin-bound iron
levels in serum and the severity of meningococ-
cal bacteremia. Production of mutants unable to
obtain iron from transferrin will be useful in
establishing whether acquisition of transferrin
iron is an important virulence factor for the
pathogenic Neisseria species.
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Chicken conalbumin, in contrast to human
transferrin, was bacteriostatic for all Neisseria
species. Transferrin and conalbumin are closely
related glycoproteins with very similar amino
acid compositions, physical properties, and iron-
binding affinities (1, 25). This suggests that the
mechanism by which gonococci and meningo-
cocci obtain iron from host iron-binding proteins
is very specific. In view of this specificity, deter-
mining whether gonococci and meningococci are
able to compete for iron with human lactoferrin
or transferrins of other species may increase our
understanding of how these pathogens might
obtain iron on human mucosal surfaces or in
animal model systems.
There was no obvious correlation between the
virulence ofgonococci and the ability to compete
with human transferrin in vitro, since nearly all
gonococcal isolates and variants effectively scav-
enged iron from transferrin. There was also no
evidence that virulent strains or colony types of
gonococci were particularly efficient scavengers
of iron from hemin or serum or that they were
able to compete more effectively with the che-
lator DF or conalbumin for iron under the con-
ditions employed in our experiments. If differ-
ences exist in the ability ofvirulent and avirulent
gonococci to scavenge iron, as suggested by
Payne and Finkelstein (19, 20) and by Payne et
al. (21), they were either too subtle to be de-
tected in the assays used in this study or were
not expressed in the in vitro systems that we
employed. Although administration of iron has
been shown to enhance infections by some men-
ingococci (11), no correlation has been found
between the virulence of these organisms in a
mouse model and the ability to compete with
transferrin, conalbumin, or other chelators in
vitro (2, 3). The resolution of apparent differ-
ences between our results obtained with in vitro
systems and those of Payne and Finkelstein in
animal models will depend on a more thorough
understanding of the biochemical mechanisms
for the acquisition of iron from sources available
in the host.
Although it is not possible to directly compare
our results with those of Payne and Finkelstein
(19, 20) and of Payne et al. (21), the observed
effects of iron on the virulence of gonococci in
the chicken embryo model may have been influ-
enced by factors other than the ability of the
gonococcal isolates to scavenge iron. For in-
stance, levels of available iron may have affected
expression of outer membrane proteins (17) to a
variable degree in different isolates, or other
factors such as colony opacity (22) could have
contributed to differences in virulence.
Some gonococci are rapidly killed in fresh
human serum (23). Our observations suggest
that a heat-labile factor(s), probably an anti-
body-activated complement, rather than iron
deprivation, mediates this bactericidal activity.
Gonococci were able to grow in heated serum,
and heated serum served as an iron source for
gonococci in medium containing DF. The almost
immediate killing of gonococci in fresh serum
also is inconsistent with the delayed effect of
iron limitation on growth of organisms in defer-
rated medium containing DF or conalbumin.
Norrod and Williams (18) and Johnson et al.
(12) found that high concentrations of ferric
ammonium citrate, but not other iron com-
pounds tested, can inhibit the rapid bactericidal
activity of fresh serum for gonococci. The signif-
icance of these observations is not clear, but is
probably unrelated to the nutritional aspects of
iron availability in serum.
Some Escherichia coli ColV plasmids (26)
and a Vibrio anguillarium plasmid (7) carry
gene-encoding systems which enhance the abil-
ity of organisms to compete with transferrin for
iron. Gonococci lacking plasmids were able to
utilize transferrin-bound iron and hemin and
were able to use these or other iron sources in
serum. Genes which code for these iron-scaveng-
ing systems in gonococci, therefore, appear to be
located on the chromosome.
The pathogenic Neisseria species clearly pos-
sess several mechanisms for obtaining essential
iron from their environment. The ability to uti-
lize human transferrin as a source of iron may
contribute to the survival of gonococci and men-
ingococci in the host. However, attributes unre-
lated to iron acquisition may be primarily re-
sponsible for differences in pathogenicity among
meningococci (2, 3, 11) and gonococci.
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